Patient characteristics
| n=37 | |
|---|---|
| Preoperative | |
| Age, median and range (years) | 72 (46–83) |
| Male/female (n) | 26/11 (70/30%) |
| BMI (kg/m2) | 26.7 (3.8) |
| Diabetes mellitus (n) | 4 (11%) |
| Hypertension (n) | 22 (60%) |
| Obstructive pulmonary disease (n) | 5 (14%) |
| Prior PCI/CABG (n) | 4 (11%) |
| Atrial fibrillation (n) | 9 (24%) |
| Pacemaker (n) | 3 (8%) |
| Creatinine (µmol/L) | 86 (19) |
| LDL cholesterol (mmol/L) | 2.9 (1.0) |
| Smoker (n) | 3 (8%) |
| Mean gradient (mm Hg) | 49.1 (15.3) |
| Aortic valve area index (cm2/m2) | 0.41 (0.11) |
| Systolic blood pressure (mm Hg) | 135 (19) |
| Heart rate at rest (bpm) | 75 (13) |
| β-blockers (n) | 12 (32%) |
| Digoxin (n) | 3 (8%) |
| ACE-/AT-II inhibitors (n) | 11 (30%) |
| Diuretics (n) | 16 (43%) |
| Calcium blockers (n) | 14 (38%) |
| Statins (n) | 20 (54%) |
| Postoperative | |
| Biological prosthesis | 20 (54%) |
| Mechanic prosthesis | 7 (19%) |
| Conduit | 1 (3%) |
| Transcatheter valve replacement | 9 (24%) |
Values are mean (SD) if not else indicated.
AT-II inhibitors, angiotensin II receptor inhibitors; BMI, body mass index; CABG, coronary artery bypass grafting; LDL, low-density lipoprotein; PCI, percutaneous coronary intervention.